N-[2-(3-tert-butylcyclobutyl)-6-cyanoindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-4-(trifluoromethyl)pyrimidine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide;N-[6-methoxy-2-(3-methoxycyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide

C130H133F18N27O14 — CID 164970645

IUPACN-[2-(3-tert-butylcyclobutyl)-6-cyanoindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-4-(trifluoromethyl)pyrimidine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide;N-[6-methoxy-2-(3-methoxycyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
SMILESCC(C)(C)C1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(C#N)cc3n2)C1.COc1cc2nn(C3CC(C(C)(C)C)C3)cc2cc1NC(=O)c1nccc(C(F)(F)F)n1.COc1cc2nn(C3CC(C(C)(C)O)C3)cc2cc1NC(=O)c1cncc(C(F)(F)F)n1.COc1cc2nn(C3CC(OC)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(C)(C)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1
InChIInChI=1S/C23H22F3N5O.C23H25F3N4O2.C22H24F3N5O2.C21H22F3N5O3.C21H21F3N4O3.C20H19F3N4O3/c1-22(2,3)15-9-16(10-15)31-12-14-8-18(13(11-27)7-19(14)30-31)29-21(32)17-5-4-6-20(28-17)23(24,25)26;1-22(2)9-7-15(8-10-22)30-13-14-11-18(19(32-3)12-17(14)29-30)28-21(31)16-5-4-6-20(27-16)23(24,25)26;1-21(2,3)13-8-14(9-13)30-11-12-7-16(17(32-4)10-15(12)29-30)27-20(31)19-26-6-5-18(28-19)22(23,24)25;1-20(2,31)12-5-13(6-12)29-10-11-4-15(17(32-3)7-14(11)28-29)27-19(30)16-8-25-9-18(26-16)21(22,23)24;1-31-18-10-16-12(11-28(27-16)13-5-7-14(29)8-6-13)9-17(18)26-20(30)15-3-2-4-19(25-15)21(22,23)24;1-29-13-7-12(8-13)27-10-11-6-16(17(30-2)9-15(11)26-27)25-19(28)14-4-3-5-18(24-14)20(21,22)23/h4-8,12,15-16H,9-10H2,1-3H3,(H,29,32);4-6,11-13,15H,7-10H2,1-3H3,(H,28,31);5-7,10-11,13-14H,8-9H2,1-4H3,(H,27,31);4,7-10,12-13,31H,5-6H2,1-3H3,(H,27,30);2-4,9-11,13-14,29H,5-8H2,1H3,(H,26,30);3-6,9-10,12-13H,7-8H2,1-2H3,(H,25,28)
InChIKeyDBRVQEYTHZARIJ-UHFFFAOYSA-N
MW2639.63 g/mol
LogP28.60
Rot. Bonds25

About N-[2-(3-tert-butylcyclobutyl)-6-cyanoindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-4-(trifluoromethyl)pyrimidine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide;N-[6-methoxy-2-(3-methoxycyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide

N-[2-(3-tert-butylcyclobutyl)-6-cyanoindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-4-(trifluoromethyl)pyrimidine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide;N-[6-methoxy-2-(3-methoxycyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide (PubChem CID 164970645) has the molecular formula C130H133F18N27O14 and a molecular weight of 2639.63 g/mol. Its IUPAC name is N-[2-(3-tert-butylcyclobutyl)-6-cyanoindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-4-(trifluoromethyl)pyrimidine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide;N-[6-methoxy-2-(3-methoxycyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide.

Molecular Properties

Compound NameN-[2-(3-tert-butylcyclobutyl)-6-cyanoindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-4-(trifluoromethyl)pyrimidine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide;N-[6-methoxy-2-(3-methoxycyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
PubChem CID164970645
Molecular FormulaC130H133F18N27O14
Molecular Weight2639.63 g/mol
Exact Mass2638.02
IUPAC NameN-[2-(3-tert-butylcyclobutyl)-6-cyanoindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-4-(trifluoromethyl)pyrimidine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide;N-[6-methoxy-2-(3-methoxycyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
SMILESCC(C)(C)C1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(C#N)cc3n2)C1.COc1cc2nn(C3CC(C(C)(C)C)C3)cc2cc1NC(=O)c1nccc(C(F)(F)F)n1.COc1cc2nn(C3CC(C(C)(C)O)C3)cc2cc1NC(=O)c1cncc(C(F)(F)F)n1.COc1cc2nn(C3CC(OC)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(C)(C)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1
InChIInChI=1S/C23H22F3N5O.C23H25F3N4O2.C22H24F3N5O2.C21H22F3N5O3.C21H21F3N4O3.C20H19F3N4O3/c1-22(2,3)15-9-16(10-15)31-12-14-8-18(13(11-27)7-19(14)30-31)29-21(32)17-5-4-6-20(28-17)23(24,25)26;1-22(2)9-7-15(8-10-22)30-13-14-11-18(19(32-3)12-17(14)29-30)28-21(31)16-5-4-6-20(27-16)23(24,25)26;1-21(2,3)13-8-14(9-13)30-11-12-7-16(17(32-4)10-15(12)29-30)27-20(31)19-26-6-5-18(28-19)22(23,24)25;1-20(2,31)12-5-13(6-12)29-10-11-4-15(17(32-3)7-14(11)28-29)27-19(30)16-8-25-9-18(26-16)21(22,23)24;1-31-18-10-16-12(11-28(27-16)13-5-7-14(29)8-6-13)9-17(18)26-20(30)15-3-2-4-19(25-15)21(22,23)24;1-29-13-7-12(8-13)27-10-11-6-16(17(30-2)9-15(11)26-27)25-19(28)14-4-3-5-18(24-14)20(21,22)23/h4-8,12,15-16H,9-10H2,1-3H3,(H,29,32);4-6,11-13,15H,7-10H2,1-3H3,(H,28,31);5-7,10-11,13-14H,8-9H2,1-4H3,(H,27,31);4,7-10,12-13,31H,5-6H2,1-3H3,(H,27,30);2-4,9-11,13-14,29H,5-8H2,1H3,(H,26,30);3-6,9-10,12-13H,7-8H2,1-2H3,(H,25,28)
InChIKeyDBRVQEYTHZARIJ-UHFFFAOYSA-N
XLogP28.60
TPSA504.27 Ų
H-Bond Donors8
H-Bond Acceptors35
Rotatable Bonds25
Heavy Atoms189
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002639.63
LogP ≤ 528.60
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1035

Analyze N-[2-(3-tert-butylcyclobutyl)-6-cyanoindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-4-(trifluoromethyl)pyrimidine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide;N-[6-methoxy-2-(3-methoxycyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[2-[4-[[[2-[[3-[[4-[2-[7-[[4-[6-cyclopropyloxy-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]methyl]-7-azaspiro[3.5]nonan-2-yl]ethylamino]-2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]methyl]-1-(2,6-dioxopiperidin-3-yl)-2-oxobenzimidazol-4-yl]methyl]spiro[3.5]nonan-7-yl]-methylamino]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 155448663
N-[2-[4-[[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]azetidin-1-yl]-[(1R,5S)-3-[2-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]ethyl]-8-[[4-[6-(2-hydroxypropan-2-yl)-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]methyl]-3,8-diazabicyclo[3.2.1]octan-6-yl]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-6-(2-fluoropropan-2-yl)pyridine-2-carboxamide
CID 155448983
N-[2-[(1R,4R)-4-[[4-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-1-yl]methyl]-3-[(2R,5R)-2-[[[1-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]-5-[6-(2-hydroxyethoxy)-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclohexyl]cyclohexyl]-6-methoxyindazol-5-yl]pyrimidine-5-carboxamide
CID 155449105
N-[2-[4-[[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]-7-azaspiro[3.5]nonan-7-yl]methyl]cyclohexyl]-6-methoxyindazol-5-yl]-4-[2-[2-[3-[[2-[[2-(2,6-dioxopiperidin-3-yl)-3-hydroxy-1-oxo-3H-isoindol-4-yl]amino]spiro[3.5]nonan-7-yl]-methylamino]propyl]-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-6-yl]-2-hydroxypropyl]-6-(2-fluoropropan-2-yl)pyridine-2-carboxamide
CID 155449549
CID 157935129
CID 157935129
CID 158940407
CID 158940407
N-[6-(1-acetylpiperidin-4-yl)oxy-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-(1-methylpiperidin-4-yl)oxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-(oxan-4-yloxy)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-piperidin-4-yloxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 164954252
N-[2-(3-tert-butylcyclobutyl)-6-[(1-methylpiperidin-4-yl)methoxy]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-(oxolan-3-yloxy)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(cyclopropylmethoxy)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 164954399
N-[6-(dimethylamino)-2-(4-hydroxycyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-methoxy-2-(4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 164970398
N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]quinoxaline-2-carboxamide;N-[6-(dimethylamino)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-ethylcyclobutyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-methylpyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-3-carboxamide
CID 164977212
N-[2-(3-tert-butylcyclobutyl)-6-(dimethylamino)indazol-5-yl]-6-fluoropyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-cyanopyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-6-(difluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]pyrazolo[3,4-b]pyridin-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;6-fluoro-N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]pyridine-2-carboxamide;N-[2-(3-hydroxy-3-methylcyclobutyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 165013662
N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-5-(trifluoromethyl)pyridine-3-carboxamide;N-[6-(dimethylamino)-2-(4,4-dimethylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-(4-hydroxy-4-methylcyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxy-4-methylcyclohexyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 165020170

Frequently Asked Questions

What is the IUPAC name of N-[2-(3-tert-butylcyclobutyl)-6-cyanoindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-4-(trifluoromethyl)pyrimidine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide;N-[6-methoxy-2-(3-methoxycyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The IUPAC name of N-[2-(3-tert-butylcyclobutyl)-6-cyanoindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-4-(trifluoromethyl)pyrimidine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide;N-[6-methoxy-2-(3-methoxycyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide (CID 164970645) is N-[2-(3-tert-butylcyclobutyl)-6-cyanoindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-4-(trifluoromethyl)pyrimidine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide;N-[6-methoxy-2-(3-methoxycyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide.
What is the SMILES notation for N-[2-(3-tert-butylcyclobutyl)-6-cyanoindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-4-(trifluoromethyl)pyrimidine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide;N-[6-methoxy-2-(3-methoxycyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The canonical SMILES for N-[2-(3-tert-butylcyclobutyl)-6-cyanoindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-4-(trifluoromethyl)pyrimidine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide;N-[6-methoxy-2-(3-methoxycyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide is CC(C)(C)C1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(C#N)cc3n2)C1.COc1cc2nn(C3CC(C(C)(C)C)C3)cc2cc1NC(=O)c1nccc(C(F)(F)F)n1.COc1cc2nn(C3CC(C(C)(C)O)C3)cc2cc1NC(=O)c1cncc(C(F)(F)F)n1.COc1cc2nn(C3CC(OC)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(C)(C)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.
What is the InChIKey of N-[2-(3-tert-butylcyclobutyl)-6-cyanoindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-4-(trifluoromethyl)pyrimidine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide;N-[6-methoxy-2-(3-methoxycyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The InChIKey is DBRVQEYTHZARIJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H22F3N5O.C23H25F3N4O2.C22H24F3N5O2.C21H22F3N5O3.C21H21F3N4O3.C20H19F3N4O3/c1-22(2,3)15-9-16(10-15)31-12-14-8-18(13(11-27)7-19(14)30-31)29-21(32)17-5-4-6-20(28-17)23(24,25)26;1-22(2)9-7-15(8-10-22)30-13-14-11-18(19(32-3)12-17(14)29-30)28-21(31)16-5-4-6-20(27-16)23(24,25)26;1-21(2,3)13-8-14(9-13)30-11-12-7-16(17(32-4)10-15(12)29-30)27-20(31)19-26-6-5-18(28-19)22(23,24)25;1-20(2,31)12-5-13(6-12)29-10-11-4-15(17(32-3)7-14(11)28-29)27-19(30)16-8-25-9-18(26-16)21(22,23)24;1-31-18-10-16-12(11-28(27-16)13-5-7-14(29)8-6-13)9-17(18)26-20(30)15-3-2-4-19(25-15)21(22,23)24;1-29-13-7-12(8-13)27-10-11-6-16(17(30-2)9-15(11)26-27)25-19(28)14-4-3-5-18(24-14)20(21,22)23/h4-8,12,15-16H,9-10H2,1-3H3,(H,29,32);4-6,11-13,15H,7-10H2,1-3H3,(H,28,31);5-7,10-11,13-14H,8-9H2,1-4H3,(H,27,31);4,7-10,12-13,31H,5-6H2,1-3H3,(H,27,30);2-4,9-11,13-14,29H,5-8H2,1H3,(H,26,30);3-6,9-10,12-13H,7-8H2,1-2H3,(H,25,28).
What are the key properties of N-[2-(3-tert-butylcyclobutyl)-6-cyanoindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-4-(trifluoromethyl)pyrimidine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide;N-[6-methoxy-2-(3-methoxycyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
N-[2-(3-tert-butylcyclobutyl)-6-cyanoindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-4-(trifluoromethyl)pyrimidine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide;N-[6-methoxy-2-(3-methoxycyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide has a molecular weight of 2639.63 g/mol, XLogP of 28.60, 25 rotatable bonds, 8 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(3-tert-butylcyclobutyl)-6-cyanoindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-4-(trifluoromethyl)pyrimidine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide;N-[6-methoxy-2-(3-methoxycyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide is sourced from PubChem (CID 164970645), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).